P38 MAP kinase inhibitors and methods for using the same

Details for Australian Patent Application No. 2006283944 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gabriel, Tobias; Soth, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2006283944

PCT Pub. Number WO2007/023114

Priority 60/712,021 25.08.05 US

Filing date 16 August 2006

Wipo publication date 1 March 2007

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/023114 Priority application(s): WO2007/023114

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283945-P38 MAP kinase inhibitors and methods for using the same

2006283941-P38 MAP kinase inhibitors and methods for using the same